According to the results of the current study, FIGN has a preliminary role in pro-tumor immunity, including natural killer cell-mediated cytotoxicity, TNF signaling, NF-kappa B signaling, Toll-like receptor signaling, and JAK-STAT signaling. The gene discussed is SOAT1; the disease is neoplasm.